Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
A comparative analysis of Denosumab (DMAB) and Zoledronic Acid (ZA) was conducted in a real-world cohort of 864 patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer with bone metastases, who were undergoing CDK4/6 inhibitors plus endocrine...
Saved in:
Similar Items
-
Testing innovative preparation tools for immersive virtual environments.
by: Federica Cavaletti, et al.
Published: (2023-06-01) -
<i>Lactobacillus rhamnosus</i> Sepsis in a Preterm Infant Following Probiotic Administration: Challenges in Diagnosis
by: Ilaria Farella, et al.
Published: (2025-01-01) -
Enlisting the Truth of Damnation: the Rhetoric of Wulfstan’s Lifelong Engagement with Eschatology
by: Federica Di Giuseppe
Published: (2024-12-01) -
EAT (in) THE CITY. An Adaptive Process of Transformation Applying the Tool of the Food Metaphor
by: Roberta Ingaramo, et al.
Published: (2024-11-01) -
Out-of-equilibrium response and fluctuation-dissipation violations across scales in flocking systems
by: Federica Ferretti, et al.
Published: (2025-07-01)